This is a type of cancer that starts in the skin glands, like hair follicles or sweat glands. It's a type of skin cancer.
Every report comes from a Lived member, sent anonymously.
Have you had Mohs Surgery for Skin Appendage Carcinoma?
Skin appendage carcinoma, more often called adnexal carcinoma, is a rare group of skin cancers that start in or resemble the skin's built-in structures: hair follicles, sweat glands and the oil-producing (sebaceous) glands. It is a family of more than 20 distinct tumor types rather than one disease, and their behavior ranges from slow and very local to more aggressive. Most appear on the head and neck as a firm bump, thickened patch or nodule that grows slowly and often causes no pain or other symptoms. Because they can look like a cyst, a common basal cell skin cancer or a harmless growth, they are easy to overlook. Two of the better-known types are microcystic adnexal carcinoma, which tends to spread quietly under the skin and along nerves well beyond what can be seen, and sebaceous carcinoma, which most often forms on the eyelid.
For most people there is no single identifiable cause. These cancers are more common in older adults, and their tendency to appear on the head and neck suggests that long-term sun (ultraviolet) exposure plays a role. A weakened immune system and previous radiation treatment to the area have also been linked to some types. Sebaceous carcinoma has a specific inherited connection. Some people with it have Muir-Torre syndrome, a form of Lynch syndrome, an inherited condition that raises the risk of colon and other internal cancers. Experts recommend that anyone diagnosed with sebaceous carcinoma be screened for it, usually by testing the tumor tissue and reviewing personal and family cancer history, because the result can change cancer screening for the person and their relatives.
Diagnosis depends on a biopsy, in which a dermatologist removes some or all of the growth so a pathologist can examine it under a microscope. Depth matters: some of these tumors sit deep in the skin, and a shallow sample can make a cancer look like a harmless growth. In one series of microcystic adnexal carcinomas, superficial biopsies led to the wrong diagnosis about a quarter of the time. Because these tumors are rare, a second opinion from a pathologist experienced with skin tumors is common. The pathologist also needs to rule out cancer that began elsewhere in the body, such as the breast or lung, and has spread to the skin, since some adnexal carcinomas look very similar under the microscope. Special stains and, increasingly, genetic tests on the tumor help make this distinction. The care team examines nearby lymph nodes and, for higher-risk types, may order scans to see whether the cancer has spread. Scans alone cannot diagnose these tumors.
For a tumor that has not spread, the main treatment is surgery to remove it completely along with a margin of healthy tissue. Mohs surgery is often preferred, especially on the face and eyelids. In this technique the surgeon removes the tumor in thin layers and checks each edge under the microscope during the same visit, continuing until no cancer remains. That matters for tumors that extend invisibly beyond what can be seen: for microcystic adnexal carcinoma, reported recurrence after Mohs surgery is roughly 0 to 12 percent, compared with 40 to 60 percent after standard wide excision. It also spares as much healthy skin as possible. Radiation therapy may be added in selected situations, such as a tumor that has come back, could not be fully removed, or has grown along nerves. In a large French study, adding radiation after complete removal did not improve outcomes, so it is not routine for every patient. If the cancer has spread to lymph nodes, surgery to remove them may be considered. For cancer that cannot be removed or has spread widely, there is no established standard treatment, because these tumors are too rare for large trials. Chemotherapy, immunotherapy or targeted drugs matched to the tumor's genetic findings may be options, and decisions are usually made by a multidisciplinary tumor board, a group of specialists who review the case together.
Most people with a skin appendage carcinoma that is found while still local are treated with surgery alone and do well. In a Dutch national registry, about 91 percent of people were alive five years after diagnosis, taking into account deaths expected from other causes. Outlook varies a great deal by type, though. A large French study found that some types, such as pilomatrical carcinoma and low-grade trichoblastic carcinoma, rarely came back, while others, including apocrine carcinoma and adnexal carcinoma not otherwise specified, returned within three years in close to a third of patients. Older age, a larger tumor and a weakened immune system were linked to less favorable results. Surgery on the face or eyelid can affect appearance or function, and reconstruction is often done at the same time or soon after. Because recurrence can appear years later, regular skin and lymph node checks are recommended, often every 6 to 12 months at first and then yearly for up to 10 years for some types. People with sebaceous carcinoma linked to Lynch syndrome also need ongoing screening for internal cancers.
See a dermatologist about a firm bump, thickened patch or sore on the skin that does not go away, keeps growing or changes, particularly on the face, scalp or neck. An eyelid lump or a patch of eyelid inflammation that does not clear with usual treatment, or keeps returning in the same spot, should be checked and biopsied, since sebaceous carcinoma is often mistaken for a chalazion (a blocked oil gland) or blepharitis. After treatment, contact your care team soon if you notice a new lump in or near the scar, numbness or tingling in the area, or a new swelling in the neck, armpit or groin where lymph nodes sit.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Skin Appendage Carcinoma is like, what's helped you, or ask the community a question.